Douglas W. Pagan is CFO at Paratek Pharmaceuticals, Inc. (PRTK). They have made 5 open-market trades across 1 company since 2017, most recently 2021-12-28.
CIK 0001628880
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PRTK | SELL · 10b5-1 | 2019-02-05 | 2019-02-07 | $6.77 | $17K | +6.6% | -8.1% | -23.7% |
| PRTK | SELL · 10b5-1 | 2018-12-12 | 2018-12-14 | $6.76 | $20K | -11.9% | +5.3% | +7.8% |
| PRTK | SELL · 10b5-1 | 2018-10-15 | 2018-10-16 | $8.96 | $25K | -18.1% | -23.2% | -34.1% |
| PRTK | SELL | 2018-10-03 | 2018-10-04 | $9.82 | $149K | -17.9% | -40.7% | -52.6% |
| PRTK | SELL | 2018-04-09 | 2018-04-10 | $12.70 | $133K | -15.1% | -15.4% | -20.1% |
| PRTK | SELL | 2018-02-05 | 2018-02-07 | $14.22 | $463K | -1.1% | +4.7% | -19.3% |
| PRTK | SELL | 2017-07-05 | 2017-07-06 | $23.58 | $195K | +2.3% | -8.1% | +7.5% |
| PRTK | SELL | 2017-06-19 | 2017-06-21 | $25.00 | $115K | +0.0% | -11.8% | +0.2% |
| PRTK | SELL · 10b5-1 | 2017-02-06 | 2017-02-08 | $15.09 | $51K | +1.0% | +7.9% | +47.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.